Arvaya Healthcare (BOM:524723) ROCE %: 7.67% (As of Mar. 2026)


BOM:524723 Arvaya Healthcare Ltd BOM:524723
34 GF Score
Price ₹67.11
GF Value ₹49.05
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Arvaya Healthcare ROCE %?

Arvaya Healthcare BOM:524723 34 ROCE % is 7.67% as of Mar. 2026. GuruFocus rates BOM:524723 with a GF Score™ of 34/100 and a GF Value™ of ₹49.05 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Arvaya Healthcare's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.67%.

Arvaya Healthcare  (BOM:524723) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Arvaya Healthcare ROCE % Related Terms

Arvaya Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Arvaya Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvaya Healthcare ROCE % Chart

Arvaya Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.60 -11.77 -3.23 5.79 2.71

Arvaya Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.99 -28.67 -14.38 -7.52 7.67
BOM:524723
34GF Score
Arvaya Healthcare Ltd BOM:524723
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvaya Healthcare ROCE % Calculation

Arvaya Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=15.079/( ( (35.896 - 0.617) + (1406.24 - 326.688) )/ 2 )
=15.079/( (35.279+1079.552)/ 2 )
=15.079/557.4155
=2.71 %

Arvaya Healthcare's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=82.788/( ( (0 - 0) + (1406.24 - 326.688) )/ 1 )
=82.788/( ( 0 + 1079.552 )/ 1 )
=82.788/1079.552
=7.67 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.67% mean?
Arvaya Healthcare (BOM:524723) has a ROCE % of 7.67% as of Mar. 2026.
Is Arvaya Healthcare's ROCE % too high?
Arvaya Healthcare's current ROCE % is 7.67%. The Medical Distribution industry median ROCE % is 8.92. Arvaya Healthcare's value of 7.67% is 14% below this industry median. Overall, Arvaya Healthcare has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's ROCE % compare to MCK and CAH?
Arvaya Healthcare's ROCE % of 7.67% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.92. Arvaya Healthcare's value of 7.67% is 14% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 8.92, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current ROCE % of 7.67% is 14% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current ROCE % is 7.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.05, compared to a current price of ₹67.11 — trading 36.8% above its estimated fair value. The current ROCE % is 7.67% and 14% below the Medical Distribution industry median of 8.92. Arvaya Healthcare's overall GF Score™ is 34/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current ROCE % is 7.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?

Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued. The current stock price of ₹67.11 is trading 36.8% above its estimated GF Value™ of ₹49.05. GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:524723:

  • ROCE %: 7.67%
  • GF Value™: ₹49.05 vs. price of ₹67.11 (36.8% above fair value)
  • GF Score™: 34/100 with 7 warning signs
  • Industry Position: 14% below the Medical Distribution median

No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arvaya Healthcare Business Description

Address G S Road, Nirvana Co Working spaces, Mezzanine Floor, Itag Plaza, ABC, Kamrup, Dispur, Gmc, Guwahati, AS, IND, 781005
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
34GF Score

Get the complete analysis for BOM:524723

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.11
Price
₹49.05
GF Value